IP Group Gelecekteki Büyüme

Future kriter kontrolleri 2/6

IP Group kazanç ve gelirinin sırasıyla yıllık 139% ve 106.6% oranında artması tahmin edilirken, EPS'nin yıllık 105.9% oranında büyümesi bekleniyor.

Anahtar bilgiler

139.0%

Kazanç büyüme oranı

105.9%

EPS büyüme oranı

Capital Markets kazanç büyümesi	18.8%
Gelir büyüme oranı	106.6%
Gelecekteki özkaynak getirisi	n/a
Analist kapsamı	Low
Son güncelleme	17 Sep 2024

Gelecekteki son büyüme güncellemeleri

Recent updates

What Type Of Shareholders Make Up IP Group Plc's (LON:IPO) Share Registry?

Dec 10

Kazanç ve Gelir Büyüme Tahminleri

LSE:IPO - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (GBP Millions )
Tarih	Gelir	Kazançlar	Serbest Nakit Akışı	Faaliyetlerden Nakit	Avg. Analist Sayısı
12/31/2026	183	N/A	-27	N/A	1
12/31/2025	167	70	-26	-26	1
12/31/2024	-2	-130	-20	-19	1
6/30/2024	-212	-226	-15	-15	N/A
3/31/2024	-184	-199	-16	-16	N/A
12/31/2023	-155	-171	-18	-18	N/A
9/30/2023	-105	-130	-21	-21	N/A
6/30/2023	-55	-88	-23	-23	N/A
3/31/2023	-179	-215	-24	-23	N/A
12/31/2022	-302	-342	-24	-23	N/A
9/30/2022	-111	-157	-21	-21	N/A
6/30/2022	79	28	-19	-18	N/A
3/31/2022	296	238	-4	-4	N/A
12/31/2021	513	449	10	10	N/A
9/30/2021	429	367	7	7	N/A
6/30/2021	346	285	5	5	N/A
3/31/2021	290	235	-11	-11	N/A
12/31/2020	234	185	-27	-27	N/A
9/30/2020	127	84	-23	-23	N/A
6/30/2020	20	-17	-18	-18	N/A
3/31/2020	-13	-46	-18	-18	N/A
12/31/2019	-47	-75	-18	-17	N/A
9/30/2019	-60	-197	-21	-19	N/A
6/30/2019	-73	-319	-23	-21	N/A
3/31/2019	-55	-306	-24	-23	N/A
12/31/2018	-36	-294	-25	-25	N/A
9/30/2018	-4	-140	-32	-32	N/A
6/30/2018	28	14	-39	-39	N/A
3/31/2018	43	32	N/A	-30	N/A
12/31/2017	58	50	N/A	-22	N/A
9/30/2017	62	41	N/A	-38	N/A
6/30/2017	66	32	N/A	-53	N/A
3/31/2017	37	9	N/A	-32	N/A
12/31/2016	8	-15	N/A	-11	N/A
9/30/2016	1	-20	N/A	6	N/A
6/30/2016	-5	-25	N/A	24	N/A
3/31/2016	47	25	N/A	-7	N/A
12/31/2015	98	75	N/A	-38	N/A
9/30/2015	93	69	N/A	-38	N/A
6/30/2015	87	63	N/A	-39	N/A
3/31/2015	58	36	N/A	-35	N/A
12/31/2014	28	9	N/A	-31	N/A
9/30/2014	65	48	N/A	-17	N/A
6/30/2014	102	88	N/A	-2	N/A
3/31/2014	94	80	N/A	12	N/A
12/31/2013	85	73	N/A	26	N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: IPO önümüzdeki 3 yıl boyunca kârsız kalmaya devam edeceği tahmin ediliyor.

Kazançlar ve Piyasa: IPO önümüzdeki 3 yıl boyunca kârsız kalmaya devam edeceği tahmin ediliyor.

Yüksek Büyüme Kazançları: IPO önümüzdeki 3 yıl boyunca kârsız kalmaya devam edeceği tahmin ediliyor.

Gelir ve Pazar: IPO şirketinin gelirinin (yıllık 106.6% ) UK pazarından (yıllık 3.5% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Geliri: IPO şirketinin gelirinin (yıllık 106.6% ) yıllık 20% dan daha hızlı büyümesi öngörülüyor.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: IPO 'un Özsermaye Getirisi'nin 3 yıl içinde yüksek olmasının öngörülüp öngörülmediğini belirlemek için yeterli veri yok

IP Group Gelecekteki Büyüme

Future kriter kontrolleri 2/6

Anahtar bilgiler

Gelecekteki son büyüme güncellemeleri

Consensus revenue estimates fall by 99%

Price target decreased by 15% to UK£1.13

Price target increased by 7.5% to UK£1.32

Price target decreased by 8.8% to UK£1.18

Price target decreased to UK£1.32

Price target decreased to UK£1.47

Recent updates

Dr. Falk Pharma GmbH acquired Kynos Therapeutics Ltd from Epidarex Capital, IP Group Plc (LSE:IPO) and Scottish Investment Bank Limited.

Visa Inc. (NYSE:V) signed a definitive agreement to acquire Featurespace from from Chrysalis Investments Limited (LSE:CHRY), Highland Europe (UK) LLP, IP Group Plc (LSE:IPO), Insight Venture Management, LLC, MissionOG Capital, LLC, and TTV Capital LLC.

Visa Inc. (NYSE:V) signed a definitive agreement to acquire Featurespace from from Chrysalis Investments Limited (LSE:CHRY), Highland Europe (UK) LLP, IP Group Plc (LSE:IPO), Insight Venture Management, LLC, MissionOG Capital, LLC, and TTV Capital LLC.

First half 2024 earnings released: UK£0.11 loss per share (vs UK£0.053 loss in 1H 2023)

New major risk - Revenue and earnings growth

Consensus revenue estimates fall by 99%

IP Group Plc to Report First Half, 2024 Results on Sep 17, 2024

Forcepoint LLC entered into a definitive agreement to acquire Garrison Technology Limited from IP Group Plc (LSE:IPO).

Price target decreased by 15% to UK£1.13

CEO & Executive Director recently sold UK£98k worth of stock

Full year 2023 earnings: EPS and revenues miss analyst expectations

Full year 2023 earnings: EPS and revenues miss analyst expectations

IP Group Plc, Annual General Meeting, Jun 12, 2024

New minor risk - Financial data availability

IP Group Plc to Report Fiscal Year 2023 Results on Mar 13, 2024

IP Group Plc (LSE:IPO) commences an Equity Buyback Plan for 103,677,065 shares, representing 10% of its issued share capital, under the authorization approved on June 15, 2023.

Price target increased by 7.5% to UK£1.32

First half 2023 earnings released: UK£0.052 loss per share (vs UK£0.30 loss in 1H 2022)

Now 21% undervalued

IP Group Plc to Report First Half, 2023 Results on Aug 02, 2023

Price target decreased by 8.8% to UK£1.18

Full year 2022 earnings released: UK£0.33 loss per share (vs UK£0.42 profit in FY 2021)

Now 24% undervalued

IP Group Plc to Report Fiscal Year 2022 Results on Mar 08, 2023

Scaleworks Inc. acquired Import.io Ltd.

IP Group plc Appoints Anita Kidgellas an Independent Non-Executive Director

Now 21% undervalued

Insufficient new directors

Insufficient new directors

Ip Group plc Announces the Initiation of Its Phase 2B Trial of Mbs2320, Its Lead Drug in Rheumatoid Arthritis, with the First Patients Now Dosed

Price target decreased to UK£1.32

First half 2022 earnings released

IP Group Plc Declares an Interim Dividend in Respect of the Period from 1 January 2022 to 30 June 2022, Payable on or Around 19 September 2022

IP Group Plc to Report First Half, 2022 Results on Aug 03, 2022

IP Group Plc Launches 'Kiko Ventures' Platform to Deepen Its Support for Transformative Climate Technology

Price target decreased to UK£1.47

Price target decreased to UK£1.47

Full year 2021 earnings: EPS and revenues exceed analyst expectations

IP Group Plc to Report Fiscal Year 2021 Results on Mar 16, 2022

Insider recently bought UK£61k worth of stock

Investor sentiment improved over the past week

First half 2021 earnings released: EPS UK£0.11 (vs UK£0.011 in 1H 2020)

NeoGenomics Laboratories, Inc. completed the acquisition of remaining 88.95% stake in Inivata Limited from a group of sellers.

IP Group Plc Announces Inaugural Dividend, Payable on 16 June 2021

Full year 2020 earnings released: EPS UK£0.17 (vs UK£0.071 loss in FY 2019)

Athenex, Inc. (NasdaqGS:ATNX) acquired Kuur Therapeutics Limited.

Full year 2020 earnings released: EPS UK£0.17 (vs UK£0.071 loss in FY 2019)

Revenue and earnings beat expectations

IP Group Plc, Annual General Meeting, Jun 09, 2021

Price target raised to UK£1.43

IP Group Plc to Report Fiscal Year 2020 Results on Mar 10, 2021

New 90-day high: UK£1.18

Centessa Pharmaceuticals Limited acquired ApcinteX from Medicxi Ventures (UK) LLP, Touchstone Innovations Plc, Cambridge Enterprise Seed Funds and IP Group Plc (LSE:IPO).

Price target raised to UK£1.24

New 90-day high: UK£0.99

What Type Of Shareholders Make Up IP Group Plc's (LON:IPO) Share Registry?

New 90-day high: UK£0.94

New 90-day high: UK£0.85

New 90-day high: UK£0.85

Integumen Plc (AIM:SKIN) reached an agreement to acquire Modern Water plc (AIM:MWG) from a group of sellers for £21.3 million.

An unknown buyer acquired an unknown stake in Frontier IP Group Plc (AIM:FIPP) from IP Group Plc (LSE:IPO).

New 90-day high - UK£0.79

Hitachi Rail Limited agreed to acquire Perpetuum Ltd.

IP Group Plc to Report First Half, 2020 Results on Aug 05, 2020

Kazanç ve Gelir Büyüme Tahminleri

Analist Gelecek Büyüme Tahminleri

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Büyüyen şirketleri keşfedin